Environmental Risk Assessment (ERA) Services for Human and Animal Drug Products
At Zenovel, we offer specialized Environmental Risk Assessment (ERA) services for both human and veterinary drug products. Our comprehensive approach evaluates the potential environmental impacts that may result from the use, storage, and disposal of pharmaceuticals, ensuring compliance with international regulatory frameworks while protecting ecosystems and public health.
For veterinary pharmaceuticals, Zenovel conducts ERAs with a focus on the environmental release of active substances via excretion from treated animals, assessing potential impacts on non-target organisms and ecological systems.
Zenovel offers end-to-end support across all stages of the ERA process:
The goal of Zenovel’s ERA services is to assess and reduce the risk of adverse environmental impacts—to human health, biodiversity, and ecosystems—while supporting the safe use, storage, and disposal of drug products. We ensure this information is clearly communicated in Summary of Product Characteristics (SmPC) documents and product labeling.
Clinical trials are crucial for drug development, but managing them is complex due to the vast amount of data and patient safety concerns. Zenovel uses innovative approaches like Risk-Based Monitoring (RBM) to streamline processes, prioritize quality, and enhance trial efficiency. This blog explores RBM’s significance in clinical trials and how
In the dynamic, rapidly changing environment of the pharmaceutical industry, product quality and regulatory compliance is mandated. Computer System Validation (CSV) is essential to that goal, since it demonstrates that computerized systems used in manufacturing, testing or managing data are reliable and compliant. This Zenovel guide gives an overview of
Pharmacokinetics (PK) is a key element of drug development, and describes how a drug interacts with the body by defining its absorption, distribution, metabolism and excretion (ADME). Knowing about PK is essential in drug development to establish the safety and efficacy of drugs (both new and generic). It is Zenovel’s
Over the past few decades, clinical trial monitoring has significantly changed from conventional on-site visits to remote and risk-based monitoring with technology. These developments revolutionized clinical trial conduct, with enhanced efficiency, cost reduction, and increased data quality. At Zenovel, we are leading the charge in excessing these innovations to optimize
The pharmaceutical industry is heavily regulated, and compliance with strict standards is crucial for operational excellence and avoiding penalties. To achieve regulatory readiness, pharmaceutical quality leaders use proactive preparation methods like mock inspections and compliance gap analysis. Zenovel guides companies through these processes to strengthen quality systems, enhance staff readiness,
Quality and compliance are paramount in the life sciences and pharmaceutical industry. Regulatory agencies like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and the World Health Organization (WHO) have established rigorous requirements that rely on a holistic approach to quality assurance (QA) and validation. At Zenovel,